INTRODUCTION
Considering that the dysbalance of enzyme activity can cause serious illnesses, the inhibitors that can selectively control proteolytic activity could be very useful for the prevention of such illnesses.
Proteolytic enzymes, that are devided into four major classes -aspartic, cysteine, metallo, serine, catalyze both intracellular and extracellular peptide cleavages during numerous physiological processes, including digestion, fertilization, growth, differentiation, immunological defence, wound healing, etc.
Proteases are also vital in the propagation of most desease processes. Thus selective inhibition of prote ases (1) is increasingly being targeted for the treatment of cancers (2) (3) (4) , parasitic, fungal and viral infec tions, e.g. malaria (5, 6) , C. albicans (7, 8) , HIV (9) (10) (11) (12) , hepatitis C (13, 14) , herpes (15, 16) , common cold (17) , inflammatory, immunological and respiratory conditions (18) (19) (20) (21) , cardiovascular (22) and degene rative disorders, including Alzheimer's disease (23, 24) .
There are now many designed potent and selective protease inhibitors that slow down or halt disease progression (25) , HIV-1 protease inhibitors being probably most studied nowadays (9) (10) (11) (12) .
Proteolytic enzymes are not completely specific, and besides a peptide bond hydrolysis, most of them also catalyze a different but related reaction, e.g. the hydrolysis of an ester bond. They differ greatly in their degree of substrate specificity, even within the same class. Thus serin proteases trypsin, elastase and chymotrypsin have about 60% identical primary structure, very similar 3D structure, nearly identical catalytic mechanism including tetrahedral transition state and the same catalytic triad (Ser-His-Asp).
However, these enzymes differ markedly in substrate specificity. Chymotrypsin requires an aromatic or bulky nonpolar side chain on the amino side of the scissile bond (next to Phe, Tyr, Trp). Trypsin requires a lysine or arginine residue, while elastase prefers small, hydrophobic residues such as alanine. X-ray stu dies have shown that these different specificities are due to quite small structural differences in the bin ding site. In chymotrypsin, a nonpolar pocket serves as a niche for the aromatic or bulky nonpolar side chain. In trypsin, one residue in this pocket is different from chymotrypsin: a serine is replaced by an aspartate (Asp 189). This aspartate in the nonpolar pocket of trypsin can form a strong electrostatic bond with a positively charged lysine or arginine side chain of a substrate. In elastase, the pocket does not exist, because the two glycine residues lining it in chymotrypsin are replaced by the much bulkier valine and threonine.
Probably, the most investigated serine protease is trypsin. Natural trypsin inhibitor is pancreatic poly peptide which binds very tightly to its active site, thus halting further proteolysis. This enzyme-inhibitor complex is exceptionally stable and its dissociation is very slow because its structure is almost perfectly complementary to that of the active site. There is a number of more or less potent trypsin inhibitors repor ted in the literature. Most of them are polypeptides (isolated or synthesized), and some of them are simple organic compunds, such as benzamidine. Most of these inhibitors have positively charged nitrogen atom which interacts with negatively charged Asp 189 in the trypsin's primary substrate binding pocket.
An alternative approach to the development of clinically useful protease inhibitors that is being investi gated recently (26) utilizes coordination chemistry of transition metal ions and their complexes.
It was found that five-coordinated titanyl sulfate completely and irreversibly blocks trypsin (27) . The direct binding of Ti(IV) to trypsin was made possible by the presence of a free carboxyl group at the bottom of the substrate binding pocket of the enzyme (Asp 189) and the five-coordinate geometry of TiO(SO 4 )(H 2 O).
It has been known that metallocenes of transition metals exhibit antitumour activity (28). These com plexes have shown antiproliferative activity against sarcoma, melanoma, colon and lung carcinoma (29) .
The applications of ferrocene in chemistry are indeed vast: it is being used in electrochemical enzyme biosensors (30) , in catalysis of chiral compounds (31), etc. Ferrocene based polymers have been shown to exhibit interesting electrochemical, optical, thermal, morphological, pharmacological and magnetic properties (32) .
Also, ferrocene unit is being inserted into the structure of already known drugs, making them more effective. The most recent example is the development of ferrocifens (33), ferrocen-substituted tamoxifen analogs, which are proven to be not only more effective against breast cancer than tamoxifen, but also with less acute toxicity. Ferrocene by itself had no effect on the proliferation of the breast cancer cells. The mechanisms of ferrocifens' action is not yet fully understood, although recent studies indicate that the ferro cifens, like their purely organic equivalents, act by changing the conformation of the receptor pro tein. In addition, when ferrocifen binds to a receptor, an oxidant/antioxidant mechanism comes into pro minant play, because carcinogenic and metastatic processes are inhibited by antioxidants and free-radical scavengers. By inserting a ferrocenyl group into the side chain of chloroquine, (a drug used for malaria treatment), much more potent and safer hybrid compound, called ferroquine, was produced (33) .
Ferrocene, an organometallic compoud with «sandwich» structure, has been chosen to study its potential inhi bitory action on trypsyn because of the cyclopentadienyl rings that have five-coordinate geometry. 
Kinetic studies of trypsin catalized hydrolysis with or without inhibition
The trypsin catalyzed hydrolysis of BAPNA was investigated spectrophotometrically (410 nm), at pH 8.2 (50 mM Tris-HCl buffer) and 37 o C in the absence and presence of ferrocene.
Reaction mixture consists (Table 1 ) of 1 ml of Tris buffer and 5 ml of a trypsin solution which was incubated at 37 o C for 5 min. Then 20 ml of BAPNA solution was added; 5 ml aliquots were taken at 0, 2 and 5 minutes of incubation and transferred to test tubes containing 0.1 ml of 30% acetic acid. In this way the reaction was terminated, and the released yellow-coloured p-nitroanilin was measured at 410 nm (34) .
In the experiments with inhibitor, 1 ml of ferrocene solution was added after 5 minutes of trypsin-Tris buffer incubation, followed by another 5 minutes of incubation at 37 o C, before the substrate solution was added (Table 2 ). Wavelength 410 nm was selected based on the UV-VIS absorption spectra of BAPNA, ferrocene and p-nitroaniline.
Molar extinction coefficients were determined for BAPNA (ξ= 30. ; literature value ξ= 10 000 M -1 cm -1 was used in calculations). The reaction velocity (v) was caclulated as initial velocity. In determining K i the reaction mixture consisted of 1 ml of Tris buffer, 5 ml of trypsin solution, 20 ml of substrate solution, with two different substrate concentrations (Table 3) . Substrate concentrations in the reaction mixture were 2.3641 mM (S 1 ) and 3.5428 mM (S 2 ).
RESULTS AND DISCUSSION

Determination of the Michaelis constant a) In the absence of ferrocene
The initial velocity at various substrate concentrations in the absence of ferrocene was obtained, as presented in Table 4 and Figures 1 and 2 . The initial velocity at various substrate concentrations in the presence of ferrocene was obtained, as presented in Table 5 and Figures 1 and 2 . Michaelis constant, K m = 2.121 mM (in the presence of ferrocene) v max = 85.68 (µmol/lmin) (in the presence of ferrocene) Determination of the inhibition constant (K i ) for ferrocene K i was determined by plotting the reaction velocity versus ferrocene concentration, at two different subs trate concentrations, according to the experimental plan in Table 3 . Results are presented in Table 6 and and Figure 3 . The inhibition constant for ferrocene determined from Figure 3 :
Determination of the inhibition constant (K i ) for benzamidine
The inhibition constant for benzamidine was determined in the same manner as K i for ferrocene, that is by plotting the reaction velocity versus benzamidine concentration, at two different substrate concentrations (data not shown).
It was determined that the inhibition constant for benzamidine is K i = 10.58 µM. The reaction rates (v) for the trypsin catalyzed hydrolysis of BAPNA, as well as K m , in the absence and in the presence of ferrocene were determined, and the obtained values were: -in the absence of ferrocene : v = 110.97 (µmol/lmin) and K m = 3.015 mM -in the presence of ferrocene : v= 85.68 (µmol/lmin) and K m = 2.121 mM.
Also, the inhibition constants for ferrocene (K i = 39.8 µM) and benzamidine (K i = 10.58 µM) were determined.
Based on the obtained reaction rates and K m values, it can be concluded that ferrocene has an inhibitory effect on trypsin. These results are in accordance with the earlier reported results (35) with casein as a substrate (decrease in the enzyme activity was found to be ≈ 25%).
It is obvious that ferrocene exhibits certain inhibitory effect on trypsin, although the inhibition type is not so obvious. The determination of Michaelis constant in the absence and in the presence of ferrocene (Fig.2) suggests a mixed-type inhibition (since the double-reciprocal plots are intercepting in the positive quadrant) or it could be that, besides the inhibitory effect, ferrocene also has an activating effect on trypsin (due to Fe 2+ ). In that case, the observed effect of ferrocene on trypsin would be the combination of the two, with the inhibition prevailing.
The inhibition constant for ferrocene (K i = 39.8 µM) was compared with the inhibition constant for benz amidine, a standard competitive trypsin inhibitor (K i =10.58 µM, under the same experimental conditi ons). The positively charged nitrogen atom of benzamidine fits into the pocket that determines the speci ficity of trypsin for positively charged amino acid residues (Lys and Arg), which is most likely the reason for the stronger inhibitory effect compared to ferrocene.
Ferrocene's modest inhibitory effect could be solely due to its five-coordinate geometry and the intro duction of the desirable functionalities in ferrocene derivatives in order to improve interaction with the enzyme's active site (especially with the negatively charged carboxylate of the trypsin Asp 189 residue) would be the logical next step in the search for better inhibition.
